Which amino acid is most likely to disrupt an α-helix due to its rigid cyclic structure?

What is the major structural role of glycine in proteins?

For an enzyme with Km=10 µM, which statement is true at [S]=10 µM under Michaelis–Menten conditions?

Which structural element is shared by all levels of protein structure?

Which structural feature defines the α-helix in protein secondary structure?

At physiological pH (~7.4), which amino acid has a positively charged side chain?

The patient has Vasopressin ordered at a rate of 0.3 units/min. The IV bag has 200 units of Vasopressin in a 500 mL bag. What rate will the nurse program the pump, in mL per hour, to deliver the prescribed dose?

Which statement about oxygen release from hemoglobin versus myoglobin is most accurate?

Which amino acid has a side chain pKa closest to physiological pH, making it suitable for proton transfer in enzyme active sites?

The following is an excerpt from a recent scientific publication:“Non‑covalent interactions lie at the bases of the molecular recognition process. In medicinal chemistry, understanding how bioactive molecules interact with their target can help to explain structure‑activity relationships (SAR) and improve potency of lead compounds. In particular, computational analysis of protein‑ligand complexes can help to unravel key interactions and guide structure‑based drug design. The literature describing protein‑ligand complexes is typically focused on few types of non‑covalent interactions … hydrophobic contacts, hydrogen bonds, and salt bridges … stacking interactions involving aromatic rings are also relatively well known … potency optimization efforts are often focused on targeting these interactions.” Which types of noncovalent interactions are frequently exploited to optimize lead compound potency, according to this excerpt?